These ESMO Clinical Practice Guidelines provide recommendations on the prevention/management of dermatological toxicities. Authorship includes a multidisciplinary group of experts from different institutions and countries in Europe and abroad. Recommendations for prevention/therapy of acneiform rash, hand-foot syndrome, alopecia, pruritus, paronychia and onycholysis are provided including levels of evidence and grades of recommendation where applicable.
Prevention and management of dermatological toxicities related to anticancer agents. ESMO Clinical Practice Guidelines / Lacouture, Me; Sibaud, V; Gerber, Pa; van den Hurk, C; Fernandez-Penas, P; Santini, D; Jahn, F; Jordan, K. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 32:2(2021), pp. 157-170. [10.1016/j.annonc.2020.11.005]
Prevention and management of dermatological toxicities related to anticancer agents. ESMO Clinical Practice Guidelines
Santini D;
2021
Abstract
These ESMO Clinical Practice Guidelines provide recommendations on the prevention/management of dermatological toxicities. Authorship includes a multidisciplinary group of experts from different institutions and countries in Europe and abroad. Recommendations for prevention/therapy of acneiform rash, hand-foot syndrome, alopecia, pruritus, paronychia and onycholysis are provided including levels of evidence and grades of recommendation where applicable.| File | Dimensione | Formato | |
|---|---|---|---|
|
Lacouture_Prevetion_2021.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
300.6 kB
Formato
Adobe PDF
|
300.6 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
